Scientific Program Highlights

Molecular Updates

  • Anaplastic thyroid cancer
  • Multiple endocrine neoplasm 2
  • Phaeochromocytoma
  • Molecular testing and targeted therapies in thyroid and adrenal cancers
  • Molecular imaging in neuroendocrine


  • Less is more in DTC: Impact of new ATAS Guidelines
  • Thyroid cytology for surgeons: With second edition Bethesda updates
  • NIFTP and low risk DTC: How to follow up post-hemithyroidectomy
  • Follicular thyroid cancer: When is completion required?
  • Management of locally advanced thyroid cancer
  • Management of non-RAI-avid and high risk thyroid cancers
  • Neuromonitoring updates: Prevention of RNL injuries and beyond
  • Controversies in management of benign disease: TIRADS, surgery for Grave's disease and Hashimoto's thyroiditis, parathyroids during thyroidectomy
  • Management of MTC: Lymph node surgery and recurrences


  • Workup and management of primary and renal hyperparathyroidism
  • Managing persistent and recurrent hyperparathyroidism
  • Evolution of surgical indications in primary hyperparathyroidism
  • Management of normocalcaemic and normohormonal primary hyperparathyroidism
  • The value of localisation studies: Review of the evidence
  • Autoflouroscence: Can we demonstrate its benefit?
  • ioPTH: How to adopt Guidelines without ioPTH
  • Renal hyperparathyroidism: Optimal timing for graft preservation


  • Workup of incidentaloma: Role of routine PET scans
  • Initial management of functional adrenal lesions
  • Understanding primary aldosteronism and AVS
  • Subclinical Cushing's: Investigations and indications for surgery
  • Large adrenal tumours without high risk features: Management options
  • Approach to management of adrenocortical carcinoma: Pros and cons of aggressive resection for locally invasive adrenocortical carcinoma
  • Impact of micro-and-macroscopically surgical margins on survival 
  • Outcomes of laparoscopic adrenal metastatectomy
  • Perioperative management of phaeo: Is alpha-blockade always needed?
  • Approach to post-operative follow up and mix of recurrent phaeochromocytoma


  • Understanding neuroendocrine syndromes
  • Endocrine features of PNETs
  • Imaging of PNETs
  • Role of surgery in PNETs: Timing and extent

Keynote Lectures

  • Thyroid surgery for differentiated thyroid cancer: Recent advances and the future
  • Technological advances for safer thyroidectomy
  • Transcriptional profiling reveals distinct classes of parathyroid tumours in PHPT
  • Focusing on quality of life for patients post treatment of thyroid cancer
  • Active surveillance of low-risk papillary microcarcinoma of the thyroid
Provisional Program coming soon.